The Hi-Point reperfusion system (.088"/.070") was non-inferior and superior to the Vecta aspiration system (.074"/.071") in successful reperfusion.
- High deliverability to M1
- High First Pass effect
- Lower use of adjunctive devices
- Similar Safety and Clinical outcomes
SUMMIT MAX: A randomized trial of the super large bore HiPoint Reperfusion System versus Vecta System for aspiration thrombectomy | Stroke ahajournals.org/doi/10.1161/…
Presented this morning at #ESOC2025 with @gdabus @ajitspuri1 et al. in Helsinki
We all need to do our part! Social distancing, masks, vaccine. The disease is treacherous and that’s the reality for now...@BaptistHealthSF#CovidVaccine
CTA can be helpful in stroke cases so you know what you’re facing: LICA occlusion with a bovine, very tortuous LCCA, aberrant subclavian; walrus bgc, distal aspiration, stentretriever #stroke
“know your enemy, know his sword”Musashi
Improvement in device technology is an amazing thing... 088 distal access sheath... good job @imperative_care and thanks to all companies that make our job easier and help improving patient outcome
The professional and personal impact of the coronavirus pandemic on US neurointerventional practices: a nationwide survey jnis.bmj.com/content/early/2…